Location History:
- London, GB (2016 - 2022)
- Surrey, GB (2020 - 2022)
Company Filing History:
11 out of 282 
6 out of 260 
4 out of 135 
Years Active: 2016-2025
Title: Innovations by Jenny McIntosh: Advancements in Gene Therapy
Introduction
Jenny McIntosh is a notable inventor based in London, GB, recognized for her impactful contributions to the field of gene therapy. With an impressive portfolio of 13 patents, she has made significant strides in developing innovative solutions that target genetic disorders.
Latest Patents
Among her latest innovations are the "Adeno-associated virus factor VIII vectors," which improve the efficiency and functionality of adeno-associated virus (AAV) vectors that produce functional Factor VIII polypeptides. This invention focuses on enhancing expression activity to better address hemophilia A. Another significant patent relates to "Factor IX encoding nucleotides," which includes polynucleotides that encode Factor IX proteins with modified coding sequences. This invention also encompasses viral particles and compositions, paving the way for advanced therapeutic applications aimed at treating hemophilia B.
Career Highlights
Throughout her career, Jenny has been associated with leading organizations that focus on medical research and innovation. Notably, she has worked at UCL Business Plc, where her expertise contributed to the commercialization of scientific advancements. Additionally, her tenure at St. Jude Children's Research Hospital has allowed her to collaborate with some of the brightest minds in the field, significantly enhancing her research impact.
Collaborations
Jenny McIntosh's work has been characterized by collaborative efforts with esteemed colleagues like Amit Nathwani and Edward Tuddenham. Through these partnerships, they have collectively advanced the understanding and treatment of genetic disorders, leveraging their expertise to drive innovation in therapeutic strategies.
Conclusion
In summary, Jenny McIntosh stands out as a leading inventor whose patents demonstrate her commitment to improving gene therapy techniques. Her innovative solutions, supported by fruitful collaborations, signify a promising future in the realm of genetic research and treatments.